Literature DB >> 23052275

Two- and three-dimensional live cell imaging of DNA damage response proteins.

Jason M Beckta1, Scott C Henderson, Kristoffer Valerie.   

Abstract

Double-strand breaks (DSBs) are the most deleterious DNA lesions a cell can encounter. If left unrepaired, DSBs harbor great potential to generate mutations and chromosomal aberrations. To prevent this trauma from catalyzing genomic instability, it is crucial for cells to detect DSBs, activate the DNA damage response (DDR), and repair the DNA. When stimulated, the DDR works to preserve genomic integrity by triggering cell cycle arrest to allow for repair to take place or force the cell to undergo apoptosis. The predominant mechanisms of DSB repair occur through nonhomologous end-joining (NHEJ) and homologous recombination repair (HRR) (reviewed in). There are many proteins whose activities must be precisely orchestrated for the DDR to function properly. Herein, we describe a method for 2- and 3-dimensional (D) visualization of one of these proteins, 53BP1. The p53-binding protein 1 (53BP1) localizes to areas of DSBs by binding to modified histones, forming foci within 5-15 minutes. The histone modifications and recruitment of 53BP1 and other DDR proteins to DSB sites are believed to facilitate the structural rearrangement of chromatin around areas of damage and contribute to DNA repair. Beyond direct participation in repair, additional roles have been described for 53BP1 in the DDR, such as regulating an intra-S checkpoint, a G2/M checkpoint, and activating downstream DDR proteins. Recently, it was discovered that 53BP1 does not form foci in response to DNA damage induced during mitosis, instead waiting for cells to enter G1 before localizing to the vicinity of DSBs. DDR proteins such as 53BP1 have been found to associate with mitotic structures (such as kinetochores) during the progression through mitosis. In this protocol we describe the use of 2- and 3-D live cell imaging to visualize the formation of 53BP1 foci in response to the DNA damaging agent camptothecin (CPT), as well as 53BP1's behavior during mitosis. Camptothecin is a topoisomerase I inhibitor that primarily causes DSBs during DNA replication. To accomplish this, we used a previously described 53BP1-mCherry fluorescent fusion protein construct consisting of a 53BP1 protein domain able to bind DSBs. In addition, we used a histone H2B-GFP fluorescent fusion protein construct able to monitor chromatin dynamics throughout the cell cycle but in particular during mitosis. Live cell imaging in multiple dimensions is an excellent tool to deepen our understanding of the function of DDR proteins in eukaryotic cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23052275      PMCID: PMC3490244          DOI: 10.3791/4251

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

1.  53BP1, a mediator of the DNA damage checkpoint.

Authors:  Bin Wang; Shuhei Matsuoka; Phillip B Carpenter; Stephen J Elledge
Journal:  Science       Date:  2002-10-03       Impact factor: 47.728

2.  Accumulation of checkpoint protein 53BP1 at DNA breaks involves its binding to phosphorylated histone H2AX.

Authors:  Irene M Ward; Kay Minn; Katherine G Jorda; Junjie Chen
Journal:  J Biol Chem       Date:  2003-04-15       Impact factor: 5.157

Review 3.  Tools to study DNA repair: what's in the box?

Authors:  Sascha Feuerhahn; Jean-Marc Egly
Journal:  Trends Genet       Date:  2008-07-31       Impact factor: 11.639

Review 4.  The DNA-damage response in human biology and disease.

Authors:  Stephen P Jackson; Jiri Bartek
Journal:  Nature       Date:  2009-10-22       Impact factor: 49.962

5.  Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks.

Authors:  Yentram Huyen; Omar Zgheib; Richard A Ditullio; Vassilis G Gorgoulis; Panayotis Zacharatos; Tom J Petty; Emily A Sheston; Hestia S Mellert; Elena S Stavridi; Thanos D Halazonetis
Journal:  Nature       Date:  2004-11-03       Impact factor: 49.962

6.  Give me a break, but not in mitosis: the mitotic DNA damage response marks DNA double-strand breaks with early signaling events.

Authors:  Simona Giunta; Stephen P Jackson
Journal:  Cell Cycle       Date:  2011-04-15       Impact factor: 4.534

7.  Enhanced fluorescence imaging of live cells by effective cytosolic delivery of probes.

Authors:  Marzia Massignani; Irene Canton; Tao Sun; Vanessa Hearnden; Sheila Macneil; Adam Blanazs; Steven P Armes; Andrew Lewis; Giuseppe Battaglia
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

8.  DNA damage signaling in response to double-strand breaks during mitosis.

Authors:  Simona Giunta; Rimma Belotserkovskaya; Stephen P Jackson
Journal:  J Cell Biol       Date:  2010-07-26       Impact factor: 10.539

9.  Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells.

Authors:  Sarah E Golding; Rhiannon N Morgan; Bret R Adams; Amy J Hawkins; Lawrence F Povirk; Kristoffer Valerie
Journal:  Cancer Biol Ther       Date:  2009-04-22       Impact factor: 4.742

10.  p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks.

Authors:  L B Schultz; N H Chehab; A Malikzay; T D Halazonetis
Journal:  J Cell Biol       Date:  2000-12-25       Impact factor: 10.539

View more
  3 in total

Review 1.  Applications of nanodosimetry in particle therapy planning and beyond.

Authors:  Antoni Rucinski; Anna Biernacka; Reinhard Schulte
Journal:  Phys Med Biol       Date:  2021-12-10       Impact factor: 3.609

2.  Orally Bioavailable and Blood-Brain Barrier-Penetrating ATM Inhibitor (AZ32) Radiosensitizes Intracranial Gliomas in Mice.

Authors:  Jeremy Karlin; Jasmine Allen; Syed F Ahmad; Gareth Hughes; Victoria Sheridan; Rajesh Odedra; Paul Farrington; Elaine B Cadogan; Lucy C Riches; Antonio Garcia-Trinidad; Andrew G Thomason; Bhavika Patel; Jennifer Vincent; Alan Lau; Kurt G Pike; Thomas A Hunt; Amrita Sule; Nicholas C K Valerie; Laura Biddlestone-Thorpe; Jenna Kahn; Jason M Beckta; Nitai Mukhopadhyay; Bernard Barlaam; Sebastien L Degorce; Jason Kettle; Nicola Colclough; Joanne Wilson; Aaron Smith; Ian P Barrett; Li Zheng; Tianwei Zhang; Yingchun Wang; Kan Chen; Martin Pass; Stephen T Durant; Kristoffer Valerie
Journal:  Mol Cancer Ther       Date:  2018-05-16       Impact factor: 6.261

3.  Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining.

Authors:  Jason M Beckta; Seth M Dever; Nisha Gnawali; Ashraf Khalil; Amrita Sule; Sarah E Golding; Elizabeth Rosenberg; Aarthi Narayanan; Kylene Kehn-Hall; Bo Xu; Lawrence F Povirk; Kristoffer Valerie
Journal:  Oncotarget       Date:  2015-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.